Results 121 to 128 of about 49,863 (128)

Recent advances on Hippo-YAP pathway in skin diseases. [PDF]

Front Immunol
Cai X, Chen K, Li X, Zhang K, Gu J, Shen C, Yu B, Huang C.   +7 more
europepmc   +1 more source

Histological and immunohistochemical findings in recurrent nevi. [PDF]

An Bras Dermatol
Okada MAMU, Heck R, Bakos RM.
europepmc   +1 more source

A Nomogram for Predicting Lung Metastasis in Papillary Thyroid Cancer Patients Aged Less Than 55 Years. [PDF]

Front Endocrinol (Lausanne)
Yang H, Qian Q, Li Y, Pan W, Peng J, Zou Z, Zhu H, Shi F.   +7 more
europepmc   +1 more source

RESEARCH CHALLENGES IN STAGE III AND IV RAS-ASSOCIATED CANCERS: A Narrative Review of the Complexities and Functions of the Family of <i>RAS</i> Genes and Ras Proteins in Housekeeping and Tumorigenesis. [PDF]

Biology (Basel)
McDonald RA, Varela-Ramirez A, Ashley AK.   +2 more
europepmc   +1 more source

Therapeutic Strategies for Drug-resistant Melanoma and Their Clinical Implications. [PDF]

J Cancer Prev
Huang K, Kim MO.
europepmc   +1 more source

Quail neuroretina c-Rmil(B-raf) proto-oncogene cDNAs encode two proteins of 93.5 and 95 kDa resulting from alternative splicing.

Oncogene, 1992
c-Rmil is the cellular allele of the v-Rmil oncogene transduced during in vitro passaging of Rous-associated virus type 1 in chicken embryonic neuroretina (NR) cells. The c-Rmil proto-oncogene is the avian homolog of the mammalian B-raf gene and belongs to the mil/raf oncogene family of serine/threonine protein kinases.
A, Eychène, J V, Barnier, P, Dézélée, M, Marx, D, Laugier, I, Calogeraki, G, Calothy   +6 more
openaire   +2 more sources

Programmed-cell-death-1-receptor-antagonists/proto-oncogene-protein-b-raf-inhibitors/mitogen-activated-protein-kinase-kinase-inhibitors

Reactions Weekly, 2018
openaire   +2 more sources